An Anesthetized Cat-and-Rat Cannabis Study Reported Both Active and Null Compound Comparisons

A 1973 study reported cardiovascular and respiratory changes after cannabis extract and THC preparations in anesthetized animals, while CBD and CBN had no observed effects at their tested rat doses. The null comparisons belong to those doses and conditions.

The experimental context was highly specific

The work used intravenous administration, anesthesia and, in cats, a controlled hindquarter perfusion preparation. These conditions differ substantially from ordinary human cannabis use. The historical THC nomenclature and preparation should be retained rather than equating every tested material with a modern product.

Multiple systems were measured

The investigators assessed blood pressure, pulse or heart rate, respiratory rate and vascular responses. The effects were not one generalized cardiovascular score. Autonomic and vascular challenge findings helped explore mechanisms but did not establish one explanation for every response.

Repeated extract exposure produced adaptation

Tolerance developed to selected cardiovascular and respiratory effects in repeatedly treated rats. That result concerns the extract regimen and measured outcomes. An initial null result for another compound does not establish general inactivity, and tolerance does not establish absence of harm.

Interpreting the evidence

The experiment is useful as a historical comparison of compounds and physiological endpoints. It does not predict human responses under different routes or prove that CBD and CBN never affect these systems. Species, anesthesia, preparation and dose are indispensable qualifications.

Related reading: interpreting cannabis tolerance claims.

Research reference

Graham JD; Li DM (1973). Cardiovascular and respiratory effects of cannabis in cat and rat. British journal of pharmacology. PubMed research record.

This analysis draws on the supplied abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

A 2021 rat-heart experiment found evidence that endogenous cannabinoid signaling modulated angiotensin II responses. The intervention and model did not establish the cardiovascular effects of using marijuana or taking THC. The preparation isolated a mechanistic question Researchers used perfused rat hearts and confirmed cardiac CB1 receptor expression. Angiotensin infusions changed…

Spread the love

Read Article: An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A 1999 isolated guinea-pig intestinal-tissue experiment found bidirectional cross-tolerance between morphine and WIN 55,212-2. Yet antagonist-triggered contraction did not appear symmetrically, limiting a simple claim that the two dependence states were identical. The model measured tissue responses Myenteric-plexus longitudinal-muscle preparations were incubated with the compounds and tested through electrically evoked…

Spread the love

Read Article: An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

A 1998 mouse study used a CB1 antagonist to precipitate withdrawal after repeated THC. Its behavioral findings support an experimental dependence model, while remaining different from the natural course of human cannabis withdrawal. The trigger was an administered antagonist After repeated THC, antagonist challenge promptly increased paw tremors and head…

Spread the love

Read Article: A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us